This website uses cookies
Read our Privacy policy and Terms of use for more information.
FREE LONGEVITY BIOTECH NEWSLETTER
Learn how treatments work and what to ask before backing a company. EverLife's free weekly newsletter gives you plain-English lessons and company overviews so you can build the skill to evaluate longevity biotech for yourself.
Free to join. No spam. Unsubscribe anytime.
No biology degree required. Educational training for independent research.
21 companies classified · 25 gates per company · 5 subsequent milestones verified · 1 financing-risk warning identified · Every original decision preserved
I spent more than 25 years building businesses, including CuraDebt, because I wanted my work to make a positive difference. Longevity biotech showed me another way to support a potentially profound impact on people's lives. My early investments also showed me how hard it is to judge an exciting pitch without understanding the science, the evidence and the economics. I built EverLife to help you learn those skills and form your own conclusions. The free newsletter starts with plain-English lessons and real company examples; the deeper 25-Gate Framework is there when you are ready.
Explain a proposed treatment in plain English and separate a promising mechanism from evidence that a finished product works.
Recognize weak trial designs and unanswered questions. Examine ownership, cash runway, dilution and the assumptions behind a valuation.
Use a repeatable worksheet to record your assessment and the next trial, financing or regulatory milestone that could change it.
See what EverLife concluded, the evidence available at the time and what happened next. Original Scout and Tracker entries remain visible, including adverse developments. A research classification is not a holding, recommendation or investment-performance result.
Use each company case to practice answering:
What important problem is being addressed?
How is the technology supposed to solve it?
What has actually been demonstrated, from laboratory and animal evidence to controlled human results?
Which companies appear best positioned scientifically and financially?
What milestone could change the conclusion?
Learn The Process. Practice On Real Companies.
Read a free lesson to see how the science and investment questions fit together. The course teaches a consistent company-evaluation process through written modules, practical exercises and worked company assessments. Learn to test evidence, examine financing and valuation assumptions, and identify the milestone that could change your conclusion.
Explore The CourseLearn one useful biotechnology evaluation concept through an emerging technology or company each week.
Free to join. No spam. Unsubscribe anytime.